GR3034891T3 - Method and kit for predicting the therapeutic response of a drug against a malignant tumour - Google Patents

Method and kit for predicting the therapeutic response of a drug against a malignant tumour

Info

Publication number
GR3034891T3
GR3034891T3 GR20000402580T GR20000402580T GR3034891T3 GR 3034891 T3 GR3034891 T3 GR 3034891T3 GR 20000402580 T GR20000402580 T GR 20000402580T GR 20000402580 T GR20000402580 T GR 20000402580T GR 3034891 T3 GR3034891 T3 GR 3034891T3
Authority
GR
Greece
Prior art keywords
tumour
cells
therapeutic response
sample
pct
Prior art date
Application number
GR20000402580T
Other languages
English (en)
Inventor
Leif Hakansson
Annika Hakansson
Bertil Gustafsson
Original Assignee
Landstinget I Oestergoetland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Landstinget I Oestergoetland filed Critical Landstinget I Oestergoetland
Publication of GR3034891T3 publication Critical patent/GR3034891T3/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
GR20000402580T 1995-05-12 2000-11-22 Method and kit for predicting the therapeutic response of a drug against a malignant tumour GR3034891T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501782A SE9501782D0 (sv) 1995-05-12 1995-05-12 Method of predicting the therapeutic response of a drug against a malignant tumour
PCT/EP1996/002007 WO1996035949A1 (en) 1995-05-12 1996-05-10 Method and kit for predicting the therapeutic response of a drug against a malignant tumour

Publications (1)

Publication Number Publication Date
GR3034891T3 true GR3034891T3 (en) 2001-02-28

Family

ID=20398299

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402580T GR3034891T3 (en) 1995-05-12 2000-11-22 Method and kit for predicting the therapeutic response of a drug against a malignant tumour

Country Status (12)

Country Link
US (1) US6114128A (el)
EP (1) EP0824696B1 (el)
JP (1) JPH11504715A (el)
AT (1) ATE196688T1 (el)
CA (1) CA2215627A1 (el)
DE (1) DE69610496T2 (el)
DK (1) DK0824696T3 (el)
ES (1) ES2151665T3 (el)
GR (1) GR3034891T3 (el)
PT (1) PT824696E (el)
SE (1) SE9501782D0 (el)
WO (1) WO1996035949A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US6087090A (en) * 1997-02-25 2000-07-11 Celtrix Pharmaceuticals, Inc. Methods for predicting drug response
US20030096237A1 (en) * 2000-08-28 2003-05-22 Ulrich Certa Determination of the ability of patients to respond to a tumor treatment
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
JP2013508329A (ja) 2009-10-19 2013-03-07 ロスタクオ・ソシエタ・ペル・アチオニ 心血管状態の薬理ゲノミクス治療のための方法およびシステム
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
CA1296622C (en) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system

Also Published As

Publication number Publication date
JPH11504715A (ja) 1999-04-27
EP0824696B1 (en) 2000-09-27
WO1996035949A1 (en) 1996-11-14
PT824696E (pt) 2001-03-30
US6114128A (en) 2000-09-05
EP0824696A1 (en) 1998-02-25
DE69610496D1 (de) 2000-11-02
ES2151665T3 (es) 2001-01-01
SE9501782D0 (sv) 1995-05-12
DE69610496T2 (de) 2001-05-10
ATE196688T1 (de) 2000-10-15
CA2215627A1 (en) 1996-11-14
DK0824696T3 (da) 2001-01-02

Similar Documents

Publication Publication Date Title
Shin et al. Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients
EP0852004A2 (en) MULTIPLEXED ANALYSIS OF CLINICAL SPECIMENS
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
CA1305928C (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
IL126314A0 (en) Monoclonal specific antibodies
ATE155820T1 (de) Prüfung zur vorhersage des ergebnisses von ivf
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
SE9500023D0 (sv) Method of detecting cancer
Bloom et al. In vitro methods in cell-mediated immunity: a progress report
NO932320L (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
PL309637A1 (en) Diagnostic test and therapy for demyelination diseases such as multiple sclerosis
GR3034891T3 (en) Method and kit for predicting the therapeutic response of a drug against a malignant tumour
Huddlestone et al. Suppressor T cells are activated in vivo in patients with multiple sclerosis coinciding with remission from acute attack.
Gopal et al. C-myc and c-myb expression in acute myelogenous leukemia
DE69839876D1 (de) Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung
Armitage et al. Normal and certain leukaemic B cells express IL-2 receptors without in vitro activation.
Emmitt et al. Crossed immunoelectrophoresis: qualitative and quantitative considerations
Nicolson et al. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies
AU4726896A (en) Detection of antibody production
IL108811A0 (en) Immunoassay reagents, kits and methods
CA2286335A1 (en) Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
SE9501780D0 (sv) Monitoring immunotherapy of malignant tumours
Bean et al. Factors That Affect the Results of Microcytotoxicity Testing in Man 1, 2, 3
IL113346A (en) Method to identify immunocompromised patients at high risk for cryptococcosis

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees